Drug-coated balloon treatment for heart attack plaques
Part of Heart & circulation clinical trials.
This study tests whether a drug-coated balloon (a balloon that releases medicine to prevent reblockage) is safe and effective for treating heart attacks caused by plaque erosion, where the artery is narrowed but not fully torn. It may help reduce the need for permanent stents.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You've recently had a heart attack (or unstable chest pain) that needs treatment
- The blocked artery must be a natural one (not a bypass graft) and must be able to be treated with a balloon or stent procedure
- Special imaging (OCT) must show a narrowing of at least 50% with a blood clot, but no major plaque rupture or heavy calcium buildup
- You must not have severe kidney disease (GFR less than 29) or a life expectancy under 2 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks patients who receive a special balloon coated with medicine (paclitaxel) to open blocked heart arteries. It aims to understand how well this treatment works for various types of blockages.
This trial tests whether a balloon coated with medicine (drug-coated balloon) can prevent future heart attacks by treating high-risk plaques in arteries that are not the one that caused your current heart attack. You may qualify if you already had a stent placed and have another mildly blocked artery with certain vulnerable features.
This trial compares two types of balloons used to open blocked heart arteries during a heart attack: one coated with medication and one that is also coated but has a special design to keep blood flowing. The goal is to see which balloon is safer and works better.
This study is testing a special balloon that releases a drug (sirolimus) to treat fatty plaques in heart arteries that are not yet blocking blood flow. The hope is that this treatment can stabilize or even shrink these plaques, reducing future risk of heart attacks. If you have recently had a heart attack and have other non-obstructive plaques, this trial might offer a new approach.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
This trial tests if a special balloon that releases medication can be used instead of a stent during emergency angioplasty for certain heart attacks. It may help patients who are having a first-time heart attack and are stable enough for the procedure.
Hear when a new Medical Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.